Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008


  Erectile Dysfunction

  Free Subscription


Articles published in Eur Urol

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    March 2008
  1. SALONIA A
    Editorial Comment on: Comparable Efficacy of Once-Daily Versus On-Demand Vardenafil in Men with Mild-to-Moderate Erectile Dysfunction: Findings of the RESTORE Study.
    Eur Urol. 2008;.
    PubMed     Related articles   


  2. ZUMBE J , Porst H, Sommer F, Grohmann W, et al
    Comparable Efficacy of Once-Daily Versus On-Demand Vardenafil in Men with Mild-to-Moderate Erectile Dysfunction: Findings of the RESTORE Study.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available


  3. PINKAWA M , Gagel B, Piroth MD, Fischedick K, et al
    Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available


  4. BRIGANTI A
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   


  5. MEULEMAN E
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   


    February 2008
  6. MUTO G
    Prostate-sparing cystectomy: two sides of the moon.
    Eur Urol. 2008;53:237-9.
    PubMed     Related articles   


    January 2008
  7. USTA MF
    Editorial Comment on: Chronic Treatment with a Type 5 Phosphodiesterase Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of Diabetic Erectile Dysfunction.
    Eur Urol. 2008;.
    PubMed     Related articles   


  8. PARK K , Ryu KS, Li WJ, Kim SW, et al
    Chronic Treatment with a Type 5 Phosphodiesterase Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of Diabetic Erectile Dysfunction.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  9. SIEVERT KD , Amend B, Stenzl A
    Tissue engineering for the lower urinary tract: a review of a state of the art approach.
    Eur Urol. 2007;52:1580-9.
    PubMed     Related articles    Abstract available


    October 2007
  10. BELLA AJ , Deyoung LX, Al-Numi M, Brock GB, et al
    Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications.
    Eur Urol. 2007;52:990-1005.
    PubMed     Related articles    Abstract available


  11. DAVIES KP , Zhao W, Tar M, Figueroa JC, et al
    Diabetes-induced changes in the alternative splicing of the slo gene in corporal tissue.
    Eur Urol. 2007;52:1229-37.
    PubMed     Related articles    Abstract available   Free Full Text


    September 2007
  12. GLINA S
    How Much are Patients Interested in Erectile Dysfunction Treatment after Radical Prostatectomy?
    Eur Urol. 2007;.
    PubMed     Related articles   


  13. SALONIA A , Gallina A, Zanni G, Briganti A, et al
    Rebuttal from Authors re: Sidney Glina. How Much are Patients Interested in Erectile Dysfunction Treatment after Radical Prostatectomy? Eur Urol. In press. doi:10.1016/j.eururo.2007.09.014.
    Eur Urol. 2007;.
    PubMed     Related articles   


  14. BRIGANTI A , Fabbri F, Salonia A, Gallina A, et al
    Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Eur Urol. 2007;52:702-7.
    PubMed     Related articles    Abstract available


    August 2007
  15. SALONIA A , Gallina A, Zanni G, Briganti A, et al
    Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical Prostatectomy.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  16. VLACHOPOULOS C , Rokkas K, Ioakeimidis N, Stefanadis C, et al
    Inflammation, Metabolic Syndrome, Erectile Dysfunction, and Coronary Artery Disease: Common Links.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  17. MICHEL MC
    Although the phosphodiesterase inhibitors have revolutionised the treatment of ED, postoperative ED due to nerve damage remains a therapeutic challenge.
    Eur Urol. 2007;52:580-1.
    PubMed     Related articles   


    July 2007
  18. VAN DER POEL HG
    Editorial Comment on: Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   


  19. STIEF C
    PDE5 Inhibitors: Is There More to Come besides Erectile Dysfunction?
    Eur Urol. 2007;.
    PubMed     Related articles   


  20. CARINI M , Masieri L, Minervini A, Lapini A, et al
    Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  21. BADALYAN R
    Editorial Comment on: Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
    Eur Urol. 2007;.
    PubMed     Related articles   


  22. TRUSS MC
    Editorial Comment on: Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
    Eur Urol. 2007;.
    PubMed     Related articles   


  23. AKBAL C , Turker P, Tavukcu HH, Simsek F, et al
    Erectile Function in Prostate Cancer-Free Patients Who Underwent Prostate Saturation Biopsy.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  24. PICKARD R
    This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
    Eur Urol. 2007;52:259-60.
    PubMed     Related articles   


  25. HATZIMOURATIDIS K , Hatzichristou D
    Testosterone and erectile function: an unresolved enigma.
    Eur Urol. 2007;52:26-8.
    PubMed     Related articles   


  26. HARRIS MJ
    The anatomic radical perineal prostatectomy: an outcomes-based evolution.
    Eur Urol. 2007;52:81-8.
    PubMed     Related articles    Abstract available


  27. LAU LC , Adaikan PG
    Effect of sildenafil and rolipram on adrenergic responses in isolated human and monkey corpus cavernosum.
    Eur Urol. 2007;52:253-8.
    PubMed     Related articles    Abstract available


    June 2007
  28. SCIARRA A
    Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?
    Eur Urol. 2007;51:1485-7.
    PubMed     Related articles   


    May 2007
  29. PICKARD R
    Editorial Comment on: Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study.
    Eur Urol. 2007;.
    PubMed     Related articles   


  30. SALONIA A
    Editorial Comment on: Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study.
    Eur Urol. 2007;.
    PubMed     Related articles   


  31. SOHLE GR
    Re: The age-related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?
    Eur Urol. 2007;51:1440.
    PubMed     Related articles   


    April 2007
  32. MORANO S , Mandosi E, Fallarino M, Gatti A, et al
    Antioxidant Treatment Associated with Sildenafil Reduces Monocyte Activation and Markers of Endothelial Damage in Patients with Diabetic Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  33. GIULIANO F
    Editorial Comment on: Peripheral Mechanisms of Erectile Dysfunction in a Rat Model of Chronic Cocaine Use.
    Eur Urol. 2007;.
    PubMed     Related articles   


    March 2007
  34. KENDIRCI M , Pradhan L, Trost L, Gur S, et al
    Peripheral Mechanisms of Erectile Dysfunction in a Rat Model of Chronic Cocaine Use.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  35. KUPELIAN V , Link CL, McKinlay JB
    Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  36. TRAISH AM , Goldstein I, Kim NN
    Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile Dysfunction.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


    January 2007
  37. KAPLAN SA , Gonzalez RR, Te AE
    Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available


  38. HATZIMOURATIDIS K
    Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.
    Eur Urol. 2007;51:278.
    PubMed     Related articles   


  39. KESSLER TM , Burkhard FC, Studer UE
    Nerve-sparing open radical retropubic prostatectomy.
    Eur Urol. 2007;51:90-7.
    PubMed     Related articles    Abstract available


  40. HATZIMOURATIDIS K , Hatzichristou D
    Phosphodiesterase type 5 inhibitors: the day after.
    Eur Urol. 2007;51:75-88.
    PubMed     Related articles    Abstract available


    December 2006
  41. MCVARY KT
    Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
    Eur Urol. 2006;50:1153-6.
    PubMed     Related articles   


  42. BROCK G
    The evolution of ED therapy in the 21st century.
    Eur Urol. 2006;50:1157-9.
    PubMed     Related articles   


    November 2006
  43. SAENZ DE TEJADA I
    Vardenafil duration of action.
    Eur Urol. 2006;50:901-2.
    PubMed     Related articles   


  44. PORST H , Sharlip ID, Hatzichristou D, Rubio-Aurioles E, et al
    Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
    Eur Urol. 2006;50:1086-94.
    PubMed     Related articles    Abstract available


    October 2006
  45. MARTIN-MORALES A , Haro JM, Beardsworth A, Bertsch J, et al
    Therapeutic Effectiveness and Patient Satisfaction after 6 Months of Treatment with Tadalafil, Sildenafil, and Vardenafil: Results from the Erectile Dysfunction Observational Study (EDOS).
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  46. DUBBELMAN YD , Dohle GR, Schroder FH
    Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome.
    Eur Urol. 2006;50:711-8.
    PubMed     Related articles    Abstract available


    September 2006
  47. FORESTA C , Caretta N, Lana A, De Toni L, et al
    Relationship Between Vascular Damage Degrees and Endothelial Progenitor Cells in Patients with Erectile Dysfunction: Effect of Vardenafil Administration and PDE5 Expression in the Bone Marrow.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  48. ZOUAOUI BOUDJELTIA K , Roumeguere T, Delree P, Moguilevsky N, et al
    Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with Vascular Erectile Dysfunction: A Preliminary Study.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  49. WILSON LC , Gilling PJ, Williams A, Kennett KM, et al
    A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.
    Eur Urol. 2006;50:569-73.
    PubMed     Related articles    Abstract available


  50. PETTERSSON B , Varenhorst E, Petas A, Sandow J, et al
    Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study.
    Eur Urol. 2006;50:483-9.
    PubMed     Related articles    Abstract available


  51. CORONA G , Mannucci E, Schulman C, Petrone L, et al
    Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.
    Eur Urol. 2006;50:595-604.
    PubMed     Related articles    Abstract available


    August 2006
  52. KENDIRCI M , Teloken PE, Champion HC, Hellstrom WJ, et al
    Gene Therapy for Erectile Dysfunction: Fact or Fiction?
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  53. JACKSON G
    Erectile Dysfunction and Vascular Risk: Let's Get It Right.
    Eur Urol. 2006;.
    PubMed     Related articles   


  54. MCMAHON CG
    Treatment of erectile dysfunction with chronic dosing of tadalafil.
    Eur Urol. 2006;50:215-7.
    PubMed     Related articles   


    July 2006
  55. MONTORSI P , Ravagnani PM, Galli S, Salonia A, et al
    Association between Erectile Dysfunction and Coronary Artery Disease: Matching the Right Target with the Right Test in the Right Patient.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  56. ROUMEGUERE T
    Rationale for Androgens and Erectile Dysfunction in 2006.
    Eur Urol. 2006;.
    PubMed     Related articles   


  57. GRECO EA , Spera G, Aversa A
    Combining Testosterone and PDE5 Inhibitors in Erectile Dysfunction: Basic Rationale and Clinical Evidences.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  58. BURNETT AL
    Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
    Eur Urol. 2006;50:29-30.
    PubMed     Related articles   


  59. HATZIMOURATIDIS K , Moysidis K, Bekos A, Tsimtsiou Z, et al
    Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study.
    Eur Urol. 2006;50:126-32.
    PubMed     Related articles    Abstract available


    March 2006
  60. JACKSON G
    The Metabolic Syndrome and Erectile Dysfunction: Multiple Vascular Risk Factors and Hypogonadism.
    Eur Urol. 2006;.
    PubMed     Related articles   


  61. PORST H , Giuliano F, Glina S, Ralph D, et al
    Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  62. HELLSTROM WJ , Kendirci M
    Type 5 Phosphodiesterase Inhibitors: Curing Erectile Dysfunction.
    Eur Urol. 2006;.
    PubMed     Related articles   


  63. STROBERG P , Hedelin H, Ljunggren C
    Prescribing All Phosphodiesterase 5 Inhibitors to a Patient with Erectile Dysfunction-A Realistic and Feasible Option in Everyday Clinical Practice-Outcomes of a Simple Treatment Regime.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


    February 2006
  64. GRUENWALD I , Shenfeld O, Chen J, Raviv G, et al
    Positive Effect of Counseling and Dose Adjustment in Patients with Erectile Dysfunction who Failed Treatment with Sildenafil.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  65. WESPES E , Amar E, Hatzichristou D, Hatzimouratidis K, et al
    Guidelines on Erectile Dysfunction: An Update.
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


    January 2006
  66. ATAN A , Delibasi T, Tuncel A
    Re: Austoni E, Mirone V, Parazzini F, Fasolo CB, Turchi P, Pescatori ES, Ricci E, Gentile V. Smoking as a Risk Factor for Erectile Dysfunction: Data From the Andrology Prevention Weeks 2001-2002, a Study of the Italian Society of Andrology (S.I.A.) [E
    Eur Urol. 2006;.
    PubMed     Related articles   


  67. MONTORSI F , Briganti A, Salonia A, Rigatti P, et al
    Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?
    Eur Urol. 2006;.
    PubMed     Related articles    Abstract available


  68. EARDLEY I
    Optimisation of PDE5 Inhibitor Therapy in Men with Erectile Dysfunction: Converting "Non-Responders" into "Responders"
    Eur Urol. 2006;.
    PubMed     Related articles   


    December 2005
  69. EL-SAKKA AI
    Prevalence of Peyronie's Disease Among Patients With Erectile Dysfunction.
    Eur Urol. 2005;.
    PubMed     Related articles    Abstract available


  70. PAPAHARITOU S , Athanasiadis L, Nakopoulou E, Kirana P, et al
    Erectile Dysfunction and Premature Ejaculation are the Most Frequently Self-Reported Sexual Concerns: Profiles of 9,536 Men Calling A Helpline.
    Eur Urol. 2005;.
    PubMed     Related articles    Abstract available


  71. MONTORSI F , Salonia A, Suardi N, Gallina A, et al
    Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy.
    Eur Urol. 2005;48:938-45.
    PubMed     Related articles    Abstract available


  72. ATAN A , Basar MM, Tuncel A
    Re: Wespes E, Rammal A, Christian G. Sildenafil non-responders: haemodynamic and morphometric studies. Eur urol 2005;48:136-9.
    Eur Urol. 2005;48:1061.
    PubMed     Related articles   


    September 2005
  73. MULHALL JP , Montorsi F
    Evaluating Preference Trials of Oral Phosphodiesterase 5 Inhibitors for Erectile Dysfunction.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  74. VLACHOPOULOS C , Rokkas K, Ioakeimidis N, Aggeli C, et al
    Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic Study.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  75. MAY F , Vroemen M, Matiasek K, Henke J, et al
    Nerve replacement strategies for cavernous nerves.
    Eur Urol 2005;48:372-8.
    PubMed     Related articles    Abstract available


    August 2005
  76. MAAS R , Wenske S, Zabel M, Ventura R, et al
    Elevation of Asymmetrical Dimethylarginine (ADMA) and Coronary Artery Disease in Men with Erectile Dysfunction.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  77. CARETTA N , Palego P, Ferlin A, Garolla A, et al
    Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: role of tadalafil.
    Eur Urol 2005;48:326-32.
    PubMed     Related articles    Abstract available


    July 2005
  78. PONHOLZER A , Temml C, Obermayr R, Wehrberger C, et al
    Is Erectile Dysfunction an Indicator for Increased Risk of Coronary Heart Disease and Stroke?
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  79. WESPES E , Rammal A, Garbar C
    Sildenafil non-responders: haemodynamic and morphometric studies.
    Eur Urol 2005;48:136-9.
    PubMed     Related articles    Abstract available


    June 2005
  80. MELMAN A , Bar-Chama N, McCullough A, Davies K, et al
    The First Human Trial for Gene Transfer Therapy for the Treatment of Erectile Dysfunction: Preliminary Results.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  81. DIBENEDETTI DB , Gondek K, Sagnier PP, Kubin M, et al
    The Treatment Satisfaction Scale: A Multidimensional Instrument for the Assessment of Treatment Satisfaction for Erectile Dysfunction Patients and Their Partners.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  82. EL-SAKKA AI
    Lower Urinary Tract Symptoms in Patients with Erectile Dysfunction: Is There a Vascular Association?
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  83. HELLMICH M , Evers T, Kubin M, Merchant S, et al
    Development and Validation of a Risk Score for Somatic Erectile Dysfunction: Combined Results from Three Cross-Sectional Surveys.
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  84. POMARA G , Morelli G
    Re: Montorsi F, Salonia A, Briganti A, Barbieri L, Zanni G, Surdi N, Cestari A, Montorsl P, Rigatti P. Vardenafil for the Treatment of Erectile Dysfunction: A Critical Review of the Literature Based on Personal Clinical Experience. Eur Urol 2005;47:61
    Eur Urol 2005;.
    PubMed     Related articles   


  85. MIRONE V , Costa P, Damber JE, Holmes S, et al
    An Evaluation of an Alternative Dosing Regimen with Tadalafil, 3 Times/Week, for Men with Erectile Dysfunction: SURE Study in 14 European Countries.
    Eur Urol 2005;47:846-54.
    PubMed     Related articles    Abstract available


  86. MCVARY KT
    Erectile Dysfunction and Lower Urinary Tract Symptoms Secondary to BPH.
    Eur Urol 2005;47:838-45.
    PubMed     Related articles    Abstract available


    May 2005
  87. MONTORSI F , Salonia A, Briganti A, Barbieri L, et al
    Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience.
    Eur Urol 2005;47:612-21.
    PubMed     Related articles    Abstract available


  88. PILATZ A , Schultheiss D, Gabouev AI, Schlote N, et al
    Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering.
    Eur Urol 2005;47:710-8.
    PubMed     Related articles    Abstract available


    April 2005
  89. HATZICHRISTOU D , Moysidis K, Apostolidis A, Bekos A, et al
    Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders.
    Eur Urol 2005;47:518-22.
    PubMed     Related articles    Abstract available


    March 2005
  90. AUSTONI E , Mirone V, Parazzini F, Fasolo CB, et al
    Smoking as a Risk Factor for Erectile Dysfunction: Data from the Andrology Prevention Weeks 2001-2002 A Study of the Italian Society of Andrology (S.I.A.).
    Eur Urol 2005;.
    PubMed     Related articles    Abstract available


  91. LEIBOVITCH I , Mor Y
    The vicious cycling: bicycling related urogenital disorders.
    Eur Urol 2005;47:277-86.
    PubMed     Related articles    Abstract available


    February 2005
  92. ROSANO GM , Aversa A, Vitale C, Fabbri A, et al
    Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk.
    Eur Urol 2005;47:214-20.
    PubMed     Related articles    Abstract available


  93. EBERT T , Jockenhovel F, Morales A, Shabsigh R, et al
    The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
    Eur Urol 2005;47:137-46.
    PubMed     Related articles    Abstract available


    January 2005
  94. BEHR-ROUSSEL D , Gorny D, Mevel K, Caisey S, et al
    Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis.
    Eur Urol 2005;47:87-91.
    PubMed     Related articles    Abstract available


    October 2004
  95. DEBRUYNE F , Barkin J, van Erps P, Reis M, et al
    Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia.
    Eur Urol 2004;46:488-94.
    PubMed     Related articles    Abstract available


  96. SAK SC , Hussain Z, Johnston C, Eardley I, et al
    What is the relationship between male sexual function and lower urinary tract symptoms (LUTS)?
    Eur Urol 2004;46:482-7.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: